Success in Phase II Clinical Trial with the Accordion-Zaleplon Product for the Treatment of Sleep Disorders >
July 17, 2011
Successful Intermediate results of Phase IIb clinical trial with Accordion Pill-Carbidopa/Levodopa for Parkinson’s disease, second group >
February 28, 2011
Success
in the first group of patients in Phase II clinical trials for the Accordion Pill Zaleplon for Sleep Disorders, intermediate results >
September 15, 2010
FDA approval for commencing Phase II trials in the US for the Accordion- Zaleplon for Sleep Disorders >
August 31, 2010
Success of Phase II b Clinical Trial with the Accordion-Pill-Levodopa Product, for the Treatment of Parkinson's disease Symptoms – Intermediate Results >
March 18, 2010
Intec Pharma announced the successful completion of phase I clinical studies with its Accordion-Pill Baclofen
(AP-Baclofen) >
February 14, 2010
Huge success in the Initial Public Offering of Intec Pharma >
February 3, 2010
Intec Pharma announces successful completion of Phase IIA with its AP-CD/LD >
|
